Neuropathy clinical trials at UCSF

1 in progress, 0 open to eligible people

Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP
Sorry, not currently recruiting here
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose regimens in pediatric subjects 2 to < 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
San Francisco, California and other locations

Last updated: July 27, 2020